# reload+after+2024-01-21 00:43:28.475962
address1§100 South Saunders Road
address2§Suite 300
city§Lake Forest
state§IL
zip§60045
country§United States
phone§224 419 7106
fax§510 744 8001
website§https://www.assertiotx.com
industry§Drug Manufacturers—Specialty & Generic
sector§Healthcare
longBusinessSummary§Assertio Holdings, Inc., a commercial pharmaceutical company, provides medicines in the areas of neurology, rheumatology, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides Sympazan, a benzodiazepine for the adjunctive treatment of seizures related with lennox-gastaut syndrome in patients aged two years of age or older; CAMBIA, a non steroidal anti inflammatory drug (NSAID) for the treatment of migraine pain, nausea, photophobia, and phonophobia; Zipsor, a NSAID for relief of mild to moderate pain in adults; SPRIX, a NSAID for the short term management of moderate to moderately severe pain that requires analgesia at the opioid level; and Otrexup, a single-dose auto-injector containing a prescription medicine and methotrexate that is used to treat patients with severe, active rheumatoid arthritis, and active polyarticular juvenile idiopathic arthritis, as well as treat adult with severe, recalcitrant, and disabling psoriasis. The company was formerly known as Assertio Therapeutics, Inc. and changed its name to Assertio Holdings, Inc. in May 2020. Assertio Holdings, Inc. was incorporated in 1995 and is headquartered in Lake Forest, Illinois.
fullTimeEmployees§30
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Daniel A. Peisert', 'age': 48, 'title': 'President, CEO & Director', 'yearBorn': 1975, 'fiscalYear': 2022, 'totalPay': 2180064, 'exercisedValue': 0, 'unexercisedValue': 986885}, {'maxAge': 1, 'name': 'Mr. Ajay  Patel', 'age': 39, 'title': 'Senior VP & CFO', 'yearBorn': 1984, 'fiscalYear': 2022, 'totalPay': 742015, 'exercisedValue': 0, 'unexercisedValue': 234219}, {'maxAge': 1, 'name': 'Mr. Bill  Iskos', 'title': 'Senior Vice President of Operations', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Sam  Schlessinger', 'title': 'Senior VP & General Counsel', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Jeff  Christensen', 'title': 'Senior Vice President of Commercial', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Howard J. Franklin M.B.A., M.D.', 'title': 'Senior Vice President of Medical', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§6
boardRisk§3
compensationRisk§3
shareHolderRightsRisk§1
overallRisk§1
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§1.038
priceToSalesTrailing12Months§0.56990844
currency§USD
dateShortInterest§1702598400
forwardEps§0.16
pegRatio§-0.01
exchange§NCM
quoteType§EQUITY
shortName§Assertio Holdings, Inc.
longName§Assertio Holdings, Inc.
firstTradeDateEpochUtc§881159400
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§b0b71d5e-e500-3f56-bb27-7703d923929a
gmtOffSetMilliseconds§-18000000
targetHighPrice§4.0
targetLowPrice§3.0
targetMeanPrice§3.5
targetMedianPrice§3.5
recommendationMean§2.0
recommendationKey§buy
numberOfAnalystOpinions§2
quickRatio§1.219
grossMargins§0.86713
ebitdaMargins§0.50755
trailingPegRatio§None
